lncRNA RMRP predicts poor prognosis and mediates tumor progression of esophageal squamous cell carcinoma by regulating miR-613/ neuropilin 2 (NRP2) axis

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• YH C, Sh L, YC C, et al. Comparative study of esophageal stent and feeding gastrostomy/jejunostomy for tracheoesophageal fistula caused by esophageal squamous cell carcinoma. PLoS One. 2012;7(8):e42766.
   PubMed Web of Science ®Google Scholar
• Hou H, Meng Z, Zhao X, et al. Survival of esophageal cancer in China: a pooled analysis on hospital-based studies from 2000 to 2018. Front Oncol. 2019;9:548.
   PubMed Web of Science ®Google Scholar
• Lau E. Non-coding RNA: zooming in on lncRNA functions. Nat Rev Genet. 2014;15(9):574–575.
   PubMed Web of Science ®Google Scholar
• Bhan A, Soleimani M, Mandal SS, et al. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77(15):3965–3981.
   PubMed Web of Science ®Google Scholar
• Cao HL, Liu ZJ, Huang PL, et al. lncRNA-RMRP promotes proliferation, migration and invasion of bladder cancer via miR-206. Eur Rev Med Pharmacol Sci. 2019;23(3):1012–1021.
   PubMed Web of Science ®Google Scholar
• Hongfeng Z, Andong J, Liwen S, et al. lncRNA RMRP knockdown suppress hepatocellular carcinoma biological activities via regulation miRNA-206/TACR1. J Cell Biochem. 2020;121(2):1690–1702.
   PubMed Web of Science ®Google Scholar
• Shao Y, Ye M, Li Q, et al. LncRNA-RMRP promotes carcinogenesis by acting as a miR-206 sponge and is used as a novel biomarker for gastric cancer. Oncotarget. 2016;7(25):37812–37824.
   PubMedGoogle Scholar
• Yang M, Ke H, Zhou W, et al. LncRNA RMRP promotes cell proliferation and invasion through miR-613/NFAT5 axis in non-small cell lung cancer. Onco Targets Ther. 2020;13:8941–8950.
   PubMedGoogle Scholar
• Zhou N, He Z, Tang H, et al. LncRNA RMRP/miR-613 axis is associated with poor prognosis and enhances the tumorigenesis of hepatocellular carcinoma by impacting oncogenic phenotypes. Am J Transl Res. 2019;11(5):2801–2815.
   PubMed Web of Science ®Google Scholar
• Su X, Gao C, Feng X, et al. miR-613 suppresses migration and invasion in esophageal squamous cell carcinoma via the targeting of G6PD. Exp Ther Med. 2020;19(4):3081–3089.
   PubMed Web of Science ®Google Scholar
• Guan S, Wang C, Chen X, et al. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma. Tumour Biol. 2016;37(4):4383–4391.
   PubMedGoogle Scholar
• Xie Z, Li T, Huang B, et al. Semaphorin 3F serves as a tumor suppressor in esophageal squamous cell carcinoma and is associated with lymph node metastasis in disease progression. Technol Cancer Res Treat. 2020;19:1533033820928117.
   Web of Science ®Google Scholar
• Luo A, Zhou X, Shi X, et al. Exosome-derived miR-339-5p mediates radiosensitivity by targeting Cdc25A in locally advanced esophageal squamous cell carcinoma. Oncogene. 2019;38(25):4990–5006.
   PubMed Web of Science ®Google Scholar
• Xiao S, Liu N, Yang X, et al. Polygalacin D suppresses esophageal squamous cell carcinoma growth and metastasis through regulating miR-142-5p/Nrf2 axis. Free Radic Biol Med. 2021;164:58–75.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Hirano S. Western blot analysis. Methods Mol Biol. 2012;926:87–97.
   PubMedGoogle Scholar
• Yan S, Xu J, Liu B, et al. Long non-coding RNA BCAR4 aggravated proliferation and migration in esophageal squamous cell carcinoma by negatively regulating p53/p21 signaling pathway. Bioengineered. 2021;12(1):682–696.
   PubMed Web of Science ®Google Scholar
• Pijuan J, Barcelo C, Moreno DF, et al. In vitro cell migration, invasion, and adhesion assays: from cell imaging to data analysis. Front Cell Dev Biol. 2019;7:107.
   PubMed Web of Science ®Google Scholar
• Han T, Zhang Y, Yang X, et al. miR-552 regulates liver tumor-initiating cell expansion and sorafenib resistance. Mol Ther Nucleic Acids. 2020;19:1073–1085.
   PubMedGoogle Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132.
   PubMed Web of Science ®Google Scholar
• Mercer TR, Mattick JS. Structure and function of long noncoding RNAs in epigenetic regulation. Nat Struct Mol Biol. 2013;20(3):300–307.
   PubMed Web of Science ®Google Scholar
• Liu B, Li X, Li C, et al. miR-25 mediates metastasis and epithelial-mesenchymal-transition in human esophageal squamous cell carcinoma via regulation of E-cadherin signaling. Bioengineered. 2019;10(1):679–688.
   PubMed Web of Science ®Google Scholar
• Zhang N, Liu JF. MicroRNA (MiR)-301a-3p regulates the proliferation of esophageal squamous cells via targeting PTEN. Bioengineered. 2020;11(1):972–983.
   PubMed Web of Science ®Google Scholar
• Liu Y, Guo C, Li F, et al. LncRNA LOXL1-AS1/miR-28-5p/SEMA7A axis facilitates pancreatic cancer progression. Cell Biochem Funct. 2020;38(1):58–65.
   PubMed Web of Science ®Google Scholar
• Chao Y, Zhou D. lncRNA-D16366 is a potential biomarker for diagnosis and prognosis of hepatocellular carcinoma. Med Sci Monit. 2019;25:6581–6586.
   PubMed Web of Science ®Google Scholar
• Kong F, Jin J, Lv X, et al. Long noncoding RNA RMRP upregulation aggravates myocardial ischemia-reperfusion injury by sponging miR-206 to target ATG3 expression. Biomed Pharmacothe. 2019;109:716–725.
   PubMed Web of Science ®Google Scholar
• Meng Q, Ren M, Li Y, et al. LncRNA-RMRP acts as an oncogene in lung cancer. PLoS One. 2016;11(12):e0164845.
   PubMed Web of Science ®Google Scholar
• Zhang SY, Huang SH, Gao SX, et al. Upregulation of lncRNA RMRP promotes the activation of cardiac fibroblasts by regulating miR‑613. Mol Med Rep. 2019;20(4):3849–3857.
   PubMed Web of Science ®Google Scholar
• Feng W, Li L, Xu X, et al. Up-regulation of the long non-coding RNA RMRP contributes to glioma progression and promotes glioma cell proliferation and invasion. Arch Med Sci. 2017;13(6):1315–1321.
   PubMed Web of Science ®Google Scholar
• Wang Y, Luo X, Liu Y, et al. Long noncoding RNA RMRP promotes proliferation and invasion via targeting miR-1-3p in non-small-cell lung cancer. J Cell Biochem. 2019;120(9):15170–15181.
   PubMed Web of Science ®Google Scholar
• Wang X, Peng L, Gong X, et al. LncRNA-RMRP promotes nucleus pulposus cell proliferation through regulating miR-206 expression. J Cell Mol Med. 2018;22(11):5468–5476.
   PubMed Web of Science ®Google Scholar
• Guo HF, Vander Kooi CW. Neuropilin functions as an essential cell surface receptor. J Biol Chem. 2015;290(49):29120–29126.
   PubMed Web of Science ®Google Scholar
• Lee G, Kang YE, Oh C, et al. Neuropilin-2 promotes growth and progression of papillary thyroid cancer cells. Auris Nasus Larynx. 2020;47(5):870–880.
   PubMed Web of Science ®Google Scholar
• Borkowetz A, Froehner M, Rauner M, et al. Neuropilin-2 is an independent prognostic factor for shorter cancer-specific survival in patients with acinar adenocarcinoma of the prostate. Int J Cancer. 2020;146(9):2619–2627.
   PubMed Web of Science ®Google Scholar